Picture of Veracyte logo

VCYT — Veracyte News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousLarge CapHigh Flyer

Veracyte Inc reports results for the quarter ended in September - Earnings Summary

* Veracyte Inc  VCYT.OQ  reported a quarterly adjusted loss
of 20 cents​​ per share for the quarter ended in September. The
mean expectation of nine analysts for the quarter was for a loss
of 16 cents per share.
* Revenue rose 73.1% to $53.86 million from a year ago; 
analysts expected $54.38 million. 
* The mean earnings estimate of analysts had risen by about 2.2%
in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Veracyte Inc shares had risen by 9.3% this quarter and
gained 3.8% so far this year.
* The company reported a quarterly loss of $14.13 million.
* Wall Street's median 12-month price target for Veracyte Inc is
$57.50 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 6 "strong buy" or "buy," 1
"hold" and 1 "sell" or "strong sell." 
This summary was machine generated November 9 at 10:03 p.m.
 ​All figures in US dollars unless otherwise stated

Recent news on Veracyte

See all news